GILEAD SCIENCES, INC. Available-for-sale Securities, Gross Realized Losses
GILEAD SCIENCES, INC. (GILD) reported Available-for-sale Securities, Gross Realized Losses of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-25.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses · last filed 2015-02-25
- GILEAD SCIENCES, INC. available-for-sale securities, gross realized losses for the quarter ending 2014-12-31 was -$175.00K, a 130.86% decline year-over-year.
- GILEAD SCIENCES, INC. available-for-sale securities, gross realized losses for the quarter ending 2014-09-30 was $84.00K, a 49.40% decline year-over-year.
- GILEAD SCIENCES, INC. available-for-sale securities, gross realized losses for the quarter ending 2014-06-30 was $66.00K, a 40.54% decline year-over-year.
- GILEAD SCIENCES, INC. available-for-sale securities, gross realized losses for the quarter ending 2014-03-31 was $25.00K, a 83.97% decline year-over-year.
- GILEAD SCIENCES, INC. available-for-sale securities, gross realized losses for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- GILEAD SCIENCES, INC. available-for-sale securities, gross realized losses for fiscal 2013 was $1.00M, a 97.73% decline from fiscal 2012.
- GILEAD SCIENCES, INC. available-for-sale securities, gross realized losses for fiscal 2012 was $44.00M, a 251.27% increase from fiscal 2011.
- GILEAD SCIENCES, INC. available-for-sale securities, gross realized losses for fiscal 2011 was $12.53M, a 242.52% increase from fiscal 2010.
| Period end | Available-for-sale Securities, Gross Realized Losses 3 month | Available-for-sale Securities, Gross Realized Losses 3 month as first filed | Available-for-sale Securities, Gross Realized Losses 6 month | Available-for-sale Securities, Gross Realized Losses 6 month as first filed | Available-for-sale Securities, Gross Realized Losses 9 month | Available-for-sale Securities, Gross Realized Losses 9 month as first filed | Available-for-sale Securities, Gross Realized Losses 12 month | Available-for-sale Securities, Gross Realized Losses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | -$175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | -$91.00K derived: sum of 2 quarters · filed 2015-02-25 | -$25.00K derived: sum of 3 quarters · filed 2015-02-25 | $0.00 10-K · filed 2015-02-25 | ||||
| 2014-09-30 | $84.00K 10-Q · filed 2014-11-05 | $150.00K derived: sum of 2 quarters · filed 2014-11-05 | $175.00K 10-Q · filed 2014-11-05 | $742.00K derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2014-06-30 | $66.00K 10-Q · filed 2014-08-04 | $91.00K 10-Q · filed 2014-08-04 | $658.00K derived: sum of 3 quarters · filed 2015-02-25 | $824.00K derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2014-03-31 | $25.00K 10-Q · filed 2014-05-07 | $592.00K derived: sum of 2 quarters · filed 2015-02-25 | $758.00K derived: sum of 3 quarters · filed 2015-02-25 | $869.00K derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-12-31 | $567.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $733.00K derived: sum of 2 quarters · filed 2015-02-25 | $844.00K derived: sum of 3 quarters · filed 2015-02-25 | $1.00M 10-K · filed 2015-02-25 | $585.00K 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $166.00K 10-Q · filed 2014-11-05 | -$166.00K 10-Q · filed 2013-10-31 | $277.00K derived: sum of 2 quarters · filed 2014-11-05 | $433.00K 10-Q · filed 2014-11-05 | -$433.00K 10-Q · filed 2013-10-31 | $88.38M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $111.00K 10-Q · filed 2014-08-04 | -$111.00K 10-Q · filed 2013-08-01 | $267.00K 10-Q · filed 2014-08-04 | -$267.00K 10-Q · filed 2013-08-01 | $88.22M derived: sum of 3 quarters · filed 2015-02-25 | $84.37M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $156.00K 10-Q · filed 2014-05-07 | -$156.00K 10-Q · filed 2013-05-08 | $88.11M derived: sum of 2 quarters · filed 2015-02-25 | $84.26M derived: sum of 3 quarters · filed 2015-02-25 | $84.25M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $87.95M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $84.10M derived: sum of 2 quarters · filed 2015-02-25 | $84.10M derived: sum of 3 quarters · filed 2015-02-25 | $44.00M 10-K · filed 2015-02-25 | $44.31M 10-K · filed 2013-02-27 | |||
| 2012-09-30 | -$3.85M 10-Q · filed 2013-10-31 | -$3.85M derived: sum of 2 quarters · filed 2013-10-31 | -$43.95M 10-Q · filed 2013-10-31 | -$29.00M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | -$5.00K 10-Q · filed 2013-08-01 | -$40.10M 10-Q · filed 2013-08-01 | -$25.15M derived: sum of 3 quarters · filed 2014-02-25 | -$25.80M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | -$40.10M 10-Q · filed 2013-05-08 | -$25.15M derived: sum of 2 quarters · filed 2014-02-25 | -$25.79M derived: sum of 3 quarters · filed 2014-02-25 | -$26.21M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $14.95M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $14.30M derived: sum of 2 quarters · filed 2014-02-25 | $13.89M derived: sum of 3 quarters · filed 2014-02-25 | $12.53M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | -$644.00K 10-Q · filed 2012-11-06 | $644.00K 10-Q · filed 2011-11-04 | -$1.06M derived: sum of 2 quarters · filed 2012-11-06 | -$2.42M 10-Q · filed 2012-11-06 | $2.42M 10-Q · filed 2011-11-04 | -$1.20M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-06-30 | -$415.00K 10-Q · filed 2012-08-01 | $415.00K 10-Q · filed 2011-08-05 | -$1.78M 10-Q · filed 2012-08-01 | $1.78M 10-Q · filed 2011-08-05 | -$554.00K derived: sum of 3 quarters · filed 2013-02-27 | -$294.00K derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-03-31 | -$1.36M 10-Q · filed 2012-05-04 | $1.36M 10-Q · filed 2011-05-09 | -$139.00K derived: sum of 2 quarters · filed 2013-02-27 | $121.00K derived: sum of 3 quarters · filed 2013-02-27 | $2.02M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2010-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $1.48M derived: sum of 2 quarters · filed 2013-02-27 | $3.38M derived: sum of 3 quarters · filed 2013-02-27 | $3.66M 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $260.00K 10-Q · filed 2011-11-04 | $2.16M derived: sum of 2 quarters · filed 2011-11-04 | $2.43M 10-Q · filed 2011-11-04 | $2.67M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-06-30 | $1.90M 10-Q · filed 2011-08-05 | -$1.90M 10-Q · filed 2010-08-09 | $2.17M 10-Q · filed 2011-08-05 | -$2.17M 10-Q · filed 2010-08-09 | $2.41M derived: sum of 3 quarters · filed 2012-02-23 | $2.62M derived: sum of 4 quarters · filed 2012-02-23 | ||
| 2010-03-31 | $274.00K 10-Q · filed 2011-05-09 | $510.00K derived: sum of 2 quarters · filed 2012-02-23 | $722.00K derived: sum of 3 quarters · filed 2012-02-23 | $116.00K derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2009-12-31 | $236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $448.00K derived: sum of 2 quarters · filed 2012-02-23 | -$158.00K derived: sum of 3 quarters · filed 2012-02-23 | $1.41M 10-K · filed 2012-02-23 | ||||
| 2009-09-30 | $212.00K 10-Q · filed 2010-11-08 | -$394.00K derived: sum of 2 quarters · filed 2010-11-08 | $1.17M 10-Q · filed 2010-11-08 | |||||
| 2009-06-30 | -$606.00K 10-Q · filed 2010-08-09 | -$957.00K 10-Q · filed 2010-08-09 | ||||||
| 2008-12-31 | $18.73M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |